Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Dingyuan Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3009-2589; OpenAlex author ID A5101079793. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination… Co-author DOI 10.1016/j.neo.2021.12.004↗
  2. Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcit… Co-author DOI 10.1093/carcin/bgz170↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ran Wei · 2 shared papers, 2020–2022 · strength 0.35
  2. Gerardo Guillermo Mackenzie · 2 shared papers, 2020–2022 · strength 0.35
  3. Cecilia Rodríguez Lanzi · 1 shared paper, 2022 · strength 0.22
  4. Basil Rigas · 1 shared paper, 2020 · strength 0.13
  5. Joseph F. LaComb · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.